Watson, IBM’s cognitive computing technology, has been at the forefront of artificial intelligence. Watson has been expanding its presence across multiple industries. Watson’s advanced cognitive computing is extending human expertise in the fields of cancer treatment, analysis in personal health, financial planning, retail, law and many others. In the healthcare sector, Watson has partnered with Memorial Sloan Kettering Cancer Care Center to help doctors make better cancer treatment choices. Most recently, in the retail space, Watson has teamed up with Macy’s to create a mobile tool that enables shoppers to ask questions while shopping in-store. In this program, Arvind Krishna, who leads the research behind Watson’s cognitive capabilities, examines the future of artificial intelligence and Watson’s implications on industries, professions and society.
Speaker:
Arvind Krishna, Senior Vice President & Director, IBM Research
Presider:
Steve Lohr, Technology Reporter, The New York Times
